메뉴 건너뛰기




Volumn 8, Issue 1, 2006, Pages

Management of chronic obstructive pulmonary disease associated with chronic bronchitis with inhaled fluticasone propionate/salmeterol (ADVAIR DISKUS) 250/50: Results of a patient experience trial

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; FLUTICASONE PROPIONATE PLUS SALMETEROL; ANDROSTANE DERIVATIVE; DRUG DERIVATIVE; FLUTICASONE PROPIONATE - SALMETEROL COMBINATION; FLUTICASONE PROPIONATE SALMETEROL COMBINATION; SALBUTAMOL;

EID: 33645360275     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (6)
  • 1
    • 0003731907 scopus 로고    scopus 로고
    • The World Health Report 2002: Reducing Risks, Promoting Healthy Life
    • World Health Organization. Available at Accessed February 27
    • World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Available at: http://www.who.int/whr/2002/en/ index.html. Accessed February 27, 2005.
    • (2005)
  • 2
    • 0037008318 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease surveillance - United States, 1971-2000
    • Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Morb Mortal Wkly Rep. 2002;51(SS-6):1-16.
    • (2002) MMWR Morb Mortal Wkly Rep , vol.51 , Issue.SS-6 , pp. 1-16
    • Mannino, D.M.1    Homa, D.M.2    Akinbami, L.J.3
  • 3
    • 1842552109 scopus 로고    scopus 로고
    • Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper
    • ATS/ERS Task Force. Abstract
    • Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-946. Abstract
    • (2004) Eur Respir J , vol.23 , pp. 932-946
    • Celli, B.R.1    MacNee, W.2
  • 4
    • 0141558800 scopus 로고    scopus 로고
    • The efficacy and safety of fluticasone propionate 250 mcg/salmeterol 50 mcg combined in the Diskus inhaler for the treatment of chronic obstructive pulmonary disease
    • Abstract
    • Hanania NA, Darken P, Horstman D, et al. The efficacy and safety of fluticasone propionate 250 mcg/salmeterol 50 mcg combined in the Diskus inhaler for the treatment of chronic obstructive pulmonary disease. Chest. 2003;124:834-843. Abstract
    • (2003) Chest , vol.124 , pp. 834-843
    • Hanania, N.A.1    Darken, P.2    Horstman, D.3
  • 5
    • 0021241325 scopus 로고
    • Overview of patient compliance with medication dosing: A literature review
    • Abstract
    • Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther. 1984;6:592-599. Abstract
    • (1984) Clin Ther , vol.6 , pp. 592-599
    • Greenberg, R.N.1
  • 6
    • 2942744348 scopus 로고    scopus 로고
    • Meeting the needs of patients with COPD: Patients' preference for the Diskus inhaler compared with the Handihaler
    • Abstract
    • Moore A, Stone S. Meeting the needs of patients with COPD: patients' preference for the Diskus inhaler compared with the Handihaler. Int J Clin Pract. 2004;58:444-450. Abstract
    • (2004) Int J Clin Pract , vol.58 , pp. 444-450
    • Moore, A.1    Stone, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.